You are now leaving GSK Malta Health Portal

You are about to leave a GSK Website. By clicking this link, you will be taken to an external website that is not owned or controlled by GSK, and GSK is not responsible for the content provided on this site. If you do not wish to leave this website, click on “Go Back” below:

Continue

Go back

MLT_GIB/OTH/0007/17m
Date of preparation: March 2018

Popup

Report an adverse event

Augmentin SR pack shot

Product overview

Augmentin (amoxicillin-clavulanate) is indicated for short-term treatment of bacterial infections caused by susceptible organisms.

 

 

Augmentin overview

Indications

Wide range of indications

Augmentin has a notably broad spectrum of activity against the commonly occurring bacterial pathogens in general practice and hospital.

Find out more
Efficacy

Efficacy

For short-term treatment of bacterial infections

Amoxicillin-clavulanate has shown efficacy in the treatment of acute bacterial rhinosinusitis (ABRS) and acute otitis media (AOM).

Learn more
Dosage and administration

Dosing & administration

Available in different strengths and forms

Several different strengths and ratios of oral amoxicillin-clavulanate are locally available.

Learn more
Video player requires JavaScript enabled. You can download this video here: https://videos.gskstatic.com/pharma/GSKpro/Malta/reliability_they_deserve_2019_video_augmentin_global_manufacturing_facility_malta.mp4
 

Augmentin Global Manufacturing

Over 30 years’ experience 

With over 30 years of experience, Augmentin is consumed by millions of patients every year around the world.

Watch the video

Video player requires JavaScript enabled. You can download this video here: https://edgesuite.gskstatic.com/HealthSites/Health/Malta/HCP/MP4/MT_9339061_Introduction_Dr_Gudrun_Maechler_Final_D1.mp4 https://edgesuite.gskstatic.com/HealthSites/Health/Malta/HCP/WEBM/MT_9339061_Introduction_Dr_Gudrun_Maechler_Final_D1.webm https://edgesuite.gskstatic.com/HealthSites/Health/Malta/HCP/OGV/MT_9339061_Introduction_Dr_Gudrun_Maechler_Final_D1.ogv
 

Antimicrobial Resistance

Appropriate antibiotic prescribing

Antimicrobial resistance (AMR) is recognised by the WHO as a serious global public health threat requiring immediate action. GSK is committed to combating AMR and supports numerous initiatives towards achieving this goal. Watch the video to learn more about the principles of appropriate prescribing to reduce AMR.

Watch the video

Augmentin is a registered trademark of the GlaxoSmithKline Group of Companies